1. Home
  2. HWKN vs IMNM Comparison

HWKN vs IMNM Comparison

Compare HWKN & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hawkins Inc.

HWKN

Hawkins Inc.

HOLD

Current Price

$149.22

Market Cap

3.0B

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$20.80

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HWKN
IMNM
Founded
1938
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.8B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
HWKN
IMNM
Price
$149.22
$20.80
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
$200.00
$32.80
AVG Volume (30 Days)
97.8K
935.4K
Earning Date
04-28-2026
06-08-2026
Dividend Yield
0.51%
N/A
EPS Growth
12.26
51.40
EPS
3.17
N/A
Revenue
$974,431,000.00
$6,941,000.00
Revenue This Year
$12.37
$18.41
Revenue Next Year
$6.30
$863.23
P/E Ratio
$47.16
N/A
Revenue Growth
6.01
N/A
52 Week Low
$101.19
$5.15
52 Week High
$186.15
$27.65

Technical Indicators

Market Signals
Indicator
HWKN
IMNM
Relative Strength Index (RSI) 53.99 40.30
Support Level $142.77 $18.98
Resistance Level $151.83 $22.57
Average True Range (ATR) 4.97 1.06
MACD 0.59 -0.17
Stochastic Oscillator 54.72 27.44

Price Performance

Historical Comparison
HWKN
IMNM

About HWKN Hawkins Inc.

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: